NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

244 hedge funds and large institutions have $4.32B invested in Neurocrine Biosciences in 2016 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 85 increasing their positions, 88 reducing their positions, and 24 closing their positions.

Holders
244
Holders Change
+13
Holders Change %
+5.63%
% of All Funds
6.52%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
39
Increased
85
Reduced
88
Closed
24
Calls
$39.2M
Puts
$8.02M
Net Calls
+$31.2M
Net Calls Change
-$37.8M

Top Buyers

1
Invesco
1
Invesco
Georgia
$131M
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$71.2M
3
Macquarie Group
3
Macquarie Group
Australia
$45.9M
4
Franklin Resources
4
Franklin Resources
California
$102M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$658M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$5.47M
2
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$1.83M
3
HM
3
HealthCor Management
New York
$0
4
PA
4
Perceptive Advisors
New York
$125M
5
CCM
5
Cadian Capital Management
New York
$1.62M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$658M 13,001,802 +304,995 +2%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$474M 9,364,314 +169,460 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$318M 6,288,257 +208,888 +3%
BB
4
BB Biotech
Switzerland
$158M 3,121,552 – –
Invesco
5
Invesco
Georgia
$131M 2,596,641 +992,680 +62%
PA
6
Perceptive Advisors
New York
$125M 2,476,272 -321,695 -11%
BIT
7
BlackRock Institutional Trust
California
$109M 2,150,949 +136,277 +7%
State Street
8
State Street
Massachusetts
$109M 2,143,468 +227,066 +12%
JHIU
9
Janus Henderson Investors US
Colorado
$108M 2,131,579 -34,994 -2%
Franklin Resources
10
Franklin Resources
California
$102M 2,012,286 +470,840 +31%
BFA
11
BlackRock Fund Advisors
California
$102M 2,009,633 +64,921 +3%
O
12
OrbiMed
New York
$91.9M 1,815,474 – –
Capital World Investors
13
Capital World Investors
California
$75M 1,481,000 – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
$71.2M 1,406,038 +990,488 +238%
Westfield Capital Management
15
Westfield Capital Management
Massachusetts
$63.6M 1,255,995 -19,580 -2%
SIG
16
Senator Investment Group
New York
$58.2M 1,150,000 +300,000 +35%
Citadel Advisors
17
Citadel Advisors
Florida
$52.5M 1,037,519 +103,974 +11%
Deutsche Bank
18
Deutsche Bank
Germany
$51.8M 1,023,195 -239,896 -19%
JPMorgan Chase & Co
19
JPMorgan Chase & Co
New York
$51.3M 1,012,428 -234,476 -19%
O
20
OppenheimerFunds
New York
$50.8M 1,002,548 +170,680 +21%
BA
21
BlackRock Advisors
Delaware
$47.8M 943,190 -17,066 -2%
EAM
22
Eagle Asset Management
Florida
$46.3M 914,500 -27,153 -3%
Macquarie Group
23
Macquarie Group
Australia
$45.9M 905,748 +645,748 +248%
BBA
24
Baker Bros. Advisors
New York
$45.3M 895,422 – –
American Century Companies
25
American Century Companies
Missouri
$44.6M 880,507 +58,980 +7%
1
2 3 4 5